VR Logo

Alkem Laboratories Ltd. download report


Healthcare | Drugs & Pharma

Alkem Laboratories Ltd. Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2022 Alkem Laboratories Ltd. Annual Report
2021 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2020 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2019 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2018 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2017 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2016 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2015 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2013 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2012 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes
2011 Alkem Laboratories Ltd. Annual Report Alkem Laboratories Ltd. chairman speech Alkem Laboratories Ltd. director's report Alkem Laboratories Ltd. management discussion Alkem Laboratories Ltd. corporate governance Alkem Laboratories Ltd. auditor's report Alkem Laboratories Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1973

Chairman: Basudeo N Singh

Managing Director: Sandeep Singh

Listing: BSE: 539523, NSE: ALKEM

Country: India

Headquarters: Mumbai, Maharashtra

Website: www.alkemlabs.com

Key Facts

Market cap: ₹35,694.94 Cr

Revenue (TTM): ₹10,479.21 Cr

Earnings (TTM): ₹1,305.14 Cr

Cash: ₹2,717.89 Cr

Total Debt: ₹2,580.12 Cr

Promoters' ownership: 57.14%

Liquidity: High

52 Week range: ₹2,828.00 - 4,070.00

Face value: ₹2.00

Shares outstanding: 11,95,65,000

10 Years Aggregate:

  • CFO: ₹5,529.13 Cr
  • EBITDA: ₹10,638.82 Cr
  • Net Profit: ₹8,726.90 Cr

Stock Performance

Time Period Alkem Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD-17.65-11.26-1.66
1 month-3.965.348.60
3 months-3.461.476.17
1 Year-14.04-11.825.82
3 Years20.5022.7622.04
5 Years9.7410.869.50
10 Years--12.2714.89
As on 08-Aug-2022
Year Alkem Laboratories S&P BSE Mid Cap S&P BSE Healthcare
202122.8239.1820.87
202040.4919.8761.45
20193.79-3.05-3.55
2018-12.43-13.31-5.89
201735.2048.130.49
20168.357.97-12.88